Company

Ercros, SA

Headquarters: Barcelona, Spain

Employees: 1,321

CEO: Mr. Antonio Zabalza Marti

BME: ECR -0.14%

Market Cap

€244.6 Million

EUR as of Jan. 1, 2024

US$270.1 Million

Market Cap History

Ercros, SA market capitalization over time

Evolution of Ercros, SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Ercros, SA

Detailed Description

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three divisions: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The Chlorine Derivatives division produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, vinyl chloride monomer and polychloride, and trichloroisocyanuric acid. Its products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; produce compound feed and in cooling equipment; and others. The Intermediate Chemicals division provides formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing resins, paints, varnishes, sockets and switches, tableware, health and packaging items, particles, and decorative laminated and plywood boards, as well as for use in the textile tanning industry. The Pharmaceuticals division engages in the manufacturing of raw materials and intermediate pharmaceutical products of antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal products. Its products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company also exports its products. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Ercros, SA has the following listings and related stock indices.


Stock: BME: ECR wb_incandescent

Stock: FSX: CRS1 wb_incandescent

Details

Headquarters:

Avinguda Diagonal, 593-595

Barcelona, 08014

Spain

Phone: 34 609 88 06 30

Fax: 34 934 30 80 73